CVSCL Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$57,949.00 |
| 52 Week High | US$77,636.00 |
| 52 Week Low | US$53,975.00 |
| Beta | 0.51 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -33.06% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSCL | CL Healthcare | CL Market | |
|---|---|---|---|
| 7D | 0% | 3.9% | 0.6% |
| 1Y | -33.1% | 5.1% | 16.8% |
Return vs Industry: CVSCL underperformed the CL Healthcare industry which returned 5.1% over the past year.
Return vs Market: CVSCL underperformed the CL Market which returned 16.8% over the past year.
Price Volatility
| CVSCL volatility | |
|---|---|
| CVSCL Average Weekly Movement | 0% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 2.9% |
| 10% most volatile stocks in CL Market | 4.8% |
| 10% least volatile stocks in CL Market | 1.6% |
Stable Share Price: CVSCL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CVSCL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVSCL fundamental statistics | |
|---|---|
| Market cap | CL$82.42t |
| Earnings (TTM) | CL$7.96t |
| Revenue (TTM) | CL$340.40t |
10.3x
P/E Ratio0.2x
P/S RatioIs CVSCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSCL income statement (TTM) | |
|---|---|
| Revenue | US$356.62b |
| Cost of Revenue | US$303.35b |
| Gross Profit | US$53.28b |
| Other Expenses | US$44.93b |
| Earnings | US$8.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 6.62 |
| Gross Margin | 14.94% |
| Net Profit Margin | 2.34% |
| Debt/Equity Ratio | 78.6% |
How did CVSCL perform over the long term?
See historical performance and comparison